Pharmaceutical Preparations
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| MONTANOVA CAPITAL, LLC | 2.02M | $50.0M | 7.82% | +1.99M | 2026-06-30 |
| Avoro Capital Advisors LLC | 1.44M | $36.0M | 5.59% | -- | 2026-06-30 |
| BAKER BROS. ADVISORS LP | 1.29M | $32.0M | 4.98% | -- | 2026-06-30 |
| Balyasny Asset Management L.P. | 1.04M | $26.0M | 4.03% | +1.03M | 2026-06-30 |
| Cormorant Asset Management, LP | 1.03M | $7.0M | 3.98% | +722.0K | 2026-06-30 |
| RA CAPITAL MANAGEMENT, L.P. | 722.0K | $18.0M | 2.79% | -- | 2026-06-30 |
| Logos Global Management LP | 722.0K | $18.0M | 2.79% | +692.0K | 2026-06-30 |
| Vivo Capital, LLC | 722.0K | $18.0M | 2.79% | -- | 2026-06-30 |
| Fairmount Funds Management LLC | 722.0K | $18.0M | 2.79% | -- | 2026-06-30 |
| Caligan Partners LP | 629.5K | $15.0M | 2.44% | +503.5K | 2026-06-30 |
